Financials
- Market Capitalization 521.45 M
- Employee 23
- Founded 2014
- CEO N/A
- Website www.ovidrx.com
- Headquarter Delaware, United States
- FIGI BBG009F0TD76
- Industry 생명공학
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
-12.81
주가매출액비율
168.21
Related tickers
| # | 이름 | 가격 | 24h % | 7d % | 1M % | 1Y % | 마켓 캡 | 이전 7일 | |
|---|---|---|---|---|---|---|---|---|---|
| 2887 | CABA Cabaletta Bio, Inc. - Common Stock | 3.11 USD | -0.32% | -1.58% | +16.48% | +111.56% | 527.29 M USD | ||
| 2888 | KYTX Kyverna Therapeutics, Inc. - Common Stock | 8.48 USD | +1.31% | +1.44% | +16.97% | +136.21% | 524.43 M USD | ||
| 2906 | ENTX Entera Bio Ltd. - Ordinary Shares | 2.95 USD | -2.64% | -13.74% | +1.37% | +52.06% | 510.77 M USD | ||
| 2940 | PRTA Prothena Corporation plc - Ordinary Shares | 9.35 USD | +0.21% | -1.68% | +14.44% | +14.44% | 480.00 M USD |